A 52-Week Study to Learn About the Safety and Effects of Ritlecitinib in Participants With Nonsegmental Vitiligo
Public ClinicalTrials.gov record NCT06163326. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A PHASE 3 RANDOMIZED WITHDRAWAL AND DOSE-UP TITRATION, MULTICENTER EXTENSION STUDY INVESTIGATING THE SAFETY, EFFICACY, AND TOLERABILITY OF RITLECITINIB IN ADULT AND ADOLESCENT PARTICIPANTS WITH NONSEGMENTAL VITILIGO
Study identification
- NCT ID
- NCT06163326
- Recruitment status
- Active, not recruiting
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Pfizer
- Industry
- Enrollment
- 394 participants
Conditions and interventions
Conditions
Interventions
- Placebo Drug
- Ritlecitinib Drug
- Ritlecitinib 100 mg Drug
Drug
Eligibility (public fields only)
- Age range
- 12 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 18, 2024
- Primary completion
- Mar 30, 2027
- Completion
- Mar 30, 2027
- Last update posted
- Apr 28, 2026
2024 – 2027
United States locations
- U.S. sites
- 22
- U.S. states
- 12
- U.S. cities
- 19
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| California Dermatology & Clinical Research Institute | Encinitas | California | 92024 | — |
| Marvel Clinical Research | Huntington Beach | California | 92647 | — |
| Wallace Medical Group, Inc | Los Angeles | California | 90056 | — |
| Encore Medical Research of Boynton Beach | Boynton Beach | Florida | 33436 | — |
| Skin Care Research | Hollywood | Florida | 33021 | — |
| ForCare Clinical Research | Tampa | Florida | 33613 | — |
| Dawes Fretzin Clinical Research Group, LLC | Indianapolis | Indiana | 46250 | — |
| DelRicht Research | Baton Rouge | Louisiana | 70809 | — |
| Lawrence J. Green, MD LLC | Rockville | Maryland | 20850 | — |
| University of Michigan | Ann Arbor | Michigan | 48109 | — |
| University of New Mexico Health Sciences Center | Albuquerque | New Mexico | 87102 | — |
| SUNY Downstate Health Sciences University | Brooklyn | New York | 11203 | — |
| University of North Carolina Medical Center | Chapel Hill | North Carolina | 27516 | — |
| Clinical & Translational Research Center (CTRC) | Chapel Hill | North Carolina | 27599 | — |
| Accellacare - Wilmington | Wilmington | North Carolina | 28411 | — |
| Wilmington Health, PLLC | Wilmington | North Carolina | 28411 | — |
| University Hospitals Cleveland Medical Center | Cleveland | Ohio | 44106 | — |
| Remington-Davis, Inc | Columbus | Ohio | 43215 | — |
| Medical University of South Carolina | Charleston | South Carolina | 29425 | — |
| Modern Research Associates, PLLC | Dallas | Texas | 75231 | — |
| Alpesh D. Desai, DO PLLC | Houston | Texas | 77008 | — |
| Austin Institute for Clinical Research | Houston | Texas | 77056 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 51 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06163326, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 28, 2026 · Synced May 7, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06163326 live on ClinicalTrials.gov.